🔎 Trials Near Me

Gara Jalqabaatti › Kansarii Hafuu Seli Xiqqaa › California › Los Angeles

Qorannoo klinikaalii Kansarii Hafuu Seli Xiqqaa Los Angeles, CA keessatti

Qorannoo 20 Kansarii Hafuu Seli Xiqqaa f Los Angeles fi naannoo isaa (kilomeetira 30 keessatti) hirmaatuu jiru. Qorannoo banaa eenyu akka hirmaatu fi akkamitti garee qorannoo akka quunnaman ilaali.

Takkalaa qorannoo (Ingiliffa)

Qorannoo hirmaatuu barbaadduu? Fuula kana jalatti agarsiisi — $99 guyyaa 30f →

The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)

Namoota walitti qabaa jiraSadarkaa 1/2
  • UCLA Jonsson Comprehensive Cancer Center, Los Angeles
  • USC Norris Comprehensive Cancer Center, Los Angeles
Umuriin 12 fi ol · Saalaa hunda · Haaromfame 02-Onk-2026 · NCT04585750

A Study With NKT3964 for Adults With Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • University of California - Los Angeles, Los Angeles
Umuriin 19 fi ol · Saalaa hunda · Haaromfame 01-Onk-2026 · NCT06586957

A Study of GSK5764227 in Participants With Relapsed Small Cell Lung Cancer (SCLC) [EMBOLD SCLC-301]

Namoota walitti qabaa jiraSadarkaa 3
  • GSK Investigational Site, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 28-Ful-2026 · NCT07099898

Safety and Efficacy of NEO212 in Patients With Astrocytoma IDH-mutant, Glioblastoma IDH-wildtype or Brain Metastasis

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of Southern California, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 24-Ful-2026 · NCT06047379

A Study of ASP546C in Adults With Gastroesophageal Cancer, Pancreatic Cancer or Other Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • START Los Angeles, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07488676

A Study of Lurbinectedin in Combination With Durvalumab for the Treatment of Participants With ES-SCLC

Namoota walitti qabaa jiraSadarkaa 2
  • Valkyrie Clinical Trials, Inc., Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07459634

BL-M14D1 Plus Atezolizumab vs Standard of Care in First-Line Extensive-Stage Small Cell Lung Cancer (BrenDeLL-Lung01)

Namoota walitti qabaa jiraSadarkaa 3
  • Valkyrie Clinical Trials, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 17-Ful-2026 · NCT07625644

AVENTINE-1: Study of AVZO-1418 as a Single Agent and in Combination Therapy in Patients With Locally Advanced or Metastatic Solid Tumors (AVZO-1418-1001)

Namoota walitti qabaa jiraSadarkaa 1/2
  • Avenzo Therapeutics Recruiting Site, Los Angeles
  • Avenzo Therapeutics Recruiting Site, Los Angeles
Umuriin 18 hanga 75 · Saalaa hunda · Haaromfame 04-Ful-2026 · NCT07038343

Study of ECI830 Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer and in Patients With Other Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • University of California LA, Los Angeles
Umuriin 18 hanga 100 · Saalaa hunda · Haaromfame 27-Hag-2026 · NCT06726148

A Clinical Study to Investigate the Efficacy and Safety of an Investigational Combination Therapy With BNT324 and BNT327 in Patients With Advanced Lung Cancer

Namoota walitti qabaa jiraSadarkaa 1/2
  • Cedars Sinai Medical Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT06892548

Phase 1 Trial of ST-001 nanoFenretinide in Relapsed/ Refractory Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 1
  • University of Southern California, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 19-Hag-2026 · NCT06922539

A Study of MGC026 in Participants With Advanced Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • The Angeles Clinic and Research Institute, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT06242470

A Study of Ifinatamab Deruxtecan Versus Treatment of Physician's Choice in Subjects With Relapsed Small Cell Lung Cancer

Namoota walitti qabaa jiraSadarkaa 3
  • UCLA Hematology-Oncology, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 06-Hag-2026 · NCT06203210

DAREON™-5: A Study to Test Whether Different Doses of BI 764532 Help People With Small Cell Lung Cancer or Other Neuroendocrine Cancers

Namoota walitti qabaa jiraSadarkaa 2
  • Valkyrie Clinical Trials, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 23-Ado-2026 · NCT05882058

A Study of Peluntamig (PT217) in Patients With Neuroendocrine Carcinomas Expressing DLL3 (the SKYBRIDGE Study)

Namoota walitti qabaa jiraSadarkaa 1/2
  • USC Norris Comprehensive Cancer Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 15-Ado-2026 · NCT05652686

Subcutaneous Tarlatamab in Participants With Extensive Stage Small Cell Lung Cancer (DeLLphi-308)

Namoota walitti qabaa jiraSadarkaa 1
  • University of Southern California, Norris Comprehensive Cancer Center, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Wax-2026 · NCT06598306

Dose Determining Study of EXS74539 (REC-4539) in Participants With Select Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1
  • Start Lacn, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Wax-2026 · NCT07517198

Comparative Effectiveness Trial of Two Supportive Cancer Care Delivery Models for Adults With Cancer

Namoota walitti qabaa jira
  • Oncology Institute for Hope and Innovation, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Elb-2026 · NCT05297734

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

Namoota walitti qabaa jiraSadarkaa 1/2
  • Research Site 125, Los Angeles
  • Research Site 133, Los Angeles
  • Research Site 103, Los Angeles
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 21-Sad-2025 · NCT05914116

Study of Bevacizumab in Combination With Chemoimmunotherapy and Atezolizumab in Patients With Extensive Stage Small Cell Lung Cancer and Liver Metastases

Namoota walitti qabaa jiraSadarkaa 2
  • Cedars-Sinai Medical Center, Samuel Oschin Comprehensive Cancer Institute, Los Angeles
Umuriin hundi · Saalaa hunda · Haaromfame 17-Sad-2025 · NCT05588388

Qorannoo Kansarii Hafuu Seli Xiqqaa magaalota biroo keessatti

Qorannoo biroo Los Angeles keessatti

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.